{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:22:00Z","timestamp":1788477720679,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Small cell neuroendocrine carcinoma of the cervix (SCNEC) is a rare and highly aggressive malignancy with a poor prognosis. We report the case of a 36-year-old nulliparous woman with a history of HPV-18 infection and repeated cytology showing atypical squamous cells of undetermined significance (ASC-US), while multiple biopsies remained negative. She initially underwent surgery for multiple uterine leiomyomas and severe endometriosis. Ten months later, she presented with acute pelvic pain, rectal pressure, and minor vaginal bleeding. Combined hysteroscopy and laparoscopy revealed suspicious lesions, and histopathology with immunohistochemistry confirmed International Federation of Gynecology and Obstetrics (FIGO) stage IVB SCNEC. Postoperatively, she received platinum-based chemotherapy followed by salvage immunotherapy. Despite a transient decline in tumor markers, the disease progressed rapidly, with enlargement and confluence of pelvic lesions and extensive bone metastases, ultimately resulting in death from multiorgan failure. This case highlights the diagnostic challenges, early systemic dissemination, and poor outcomes of SCNEC, underscoring the urgent need for more effective therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fonc.2025.1692412","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T05:17:55Z","timestamp":1762751875000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Diagnostic challenges in cervical small cell neuroendocrine carcinoma of a reproductive-age woman"],"prefix":"10.3389","volume":"15","author":[{"given":"Yitong","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000504","article-title":"Updates and management algorithm for neuroendocrine tumors of the uterine cervix","volume":"29","author":"Salvo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"B2","article-title":"Small cell neuroendocrine carcinoma","volume-title":"WHO Classification of Tumours: Female Genital Tumours","author":"Alvarado-Cabrero","year":"2020"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog5110235","article-title":"Strategic approaches in management of early-stage cervical cancer: a comprehensive editorial","volume":"51","author":"Golia D\u2019Aug\u00e8","year":"2024","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000494538","article-title":"Clinicopathological aspects of small cell neuroendocrine carcinoma of the uterine cervix: a multicenter retrospective study and meta-analysis","volume":"50","author":"Xu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2014.450","article-title":"Neuroendocrine carcinoma of the cervix presenting as intractable hyponatremic seizures due to paraneoplastic SIADH: a rare case report and brief review of the literature","volume":"8","author":"Kuriakose","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3562","article-title":"Ectopic insulin secretion by a large-cell neuroendocrine carcinoma of the cervix","volume":"9","author":"Wang","year":"2020","journal-title":"Clin Case Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2025.101704","article-title":"Small cell carcinoma of the cervix with syndrome of inappropriate antidiuretic hormone secretion following chemotherapy: A case report and literature review","volume":"58","author":"Lauzon","year":"2025","journal-title":"Gynecol Oncol Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ccr3.1904","article-title":"A patient with solid gynecologic cancer causing lactic acidosis, severe hypercalcemia, and hypoglycemia","volume":"7","author":"Hausken","year":"2018","journal-title":"Clin Case Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3802\/jgo.2011.22.1.39","article-title":"Pap smear screening for small cell carcinoma of the uterine cervix: a case series and review of the literature","volume":"22","author":"Park","year":"2011","journal-title":"J Gynecol Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1186\/s12885-024-12920-4","article-title":"Relationship between p16\/Ki67 immunoscores and PAX1\/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women","volume":"24","author":"Luo","year":"2024","journal-title":"BMC Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.36129\/jog.2025.199","article-title":"Precision and progress: minimally invasive surgery in gynaecologic cancer treatment","volume":"37","author":"Golia D\u2019Aug\u00e8","year":"2025","journal-title":"J Obstet Gynaecol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e945078","DOI":"10.12659\/AJCR.945078","article-title":"Cervical neuroendocrine carcinoma presenting as isolated large ovarian metastasis: a case report","volume":"26","author":"Faridzi","year":"2025","journal-title":"Am J Case Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s12885-018-4447-x","article-title":"Neuroendocrine carcinoma of the cervix: a systematic review of the literature","volume":"18","author":"Tempfer","year":"2018","journal-title":"BMC Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181d1d457","article-title":"An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms that are commonly TTF1 positive and which may express CK20 and P63","volume":"34","author":"McCluggage","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.11.020","article-title":"A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases","volume":"144","author":"Kuji","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/or.2023.11764","article-title":"Advances in research, diagnosis, and treatment of neuroendocrine cervical carcinoma: a review","volume":"17","author":"Ren","year":"2023","journal-title":"Oncol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071835","article-title":"Neuroendocrine neoplasms of the gynecologic tract","volume":"14","author":"Virarkar","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.critrevonc.2017.10.007","article-title":"Ovarian sex-cord stromal tumours and small cell tumours: pathological, genetic and management aspects","volume":"120","author":"Boussios","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0433","article-title":"SMARCA4: implications of an altered chromatin-remodeling gene for cancer development and therapy","volume":"20","author":"Mardinian","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001649","article-title":"Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix","volume":"30","author":"Carroll","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30098-5","article-title":"Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1\/2 trial","volume":"17","author":"Antonia","year":"2016","journal-title":"Lancet Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004573","article-title":"Complete response to combination nivolumab and ipilimumab in recurrent neuroendocrine carcinoma of the cervix","volume":"138","author":"Paterniti","year":"2021","journal-title":"Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102385","article-title":"Integration of immunotherapy into treatment of cervical cancer: recent data and ongoing trials","volume":"106","author":"Monk","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.8072","article-title":"Current treatment strategies and future directions for extrapulmonary neuroendocrine carcinomas: a review","volume":"7","author":"Stelwagen","year":"2021","journal-title":"JAMA Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.04.019","article-title":"The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix","volume":"161","author":"Pei","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00248","article-title":"Unique genomic landscape of high-grade neuroendocrine cervical carcinoma: implications for rethinking current treatment paradigms","volume":"4","author":"Eskander","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26860","DOI":"10.1038\/s41598-025-12112-5","article-title":"Significant prognostic value of cell-cycle proteins in early-stage small cell carcinoma of cervix","volume":"15","author":"Xu","year":"2025","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004708","article-title":"Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study","volume":"33","author":"Salvo","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e4","article-title":"Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study","volume":"34","author":"Seino","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2016.59.2.116","article-title":"Prognostic factors in neuroendocrine cervical carcinoma","volume":"59","author":"Lee","year":"2016","journal-title":"Obstet Gynecol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.10.027","article-title":"Prognostic factors and optimal therapy for stages I\u2013II neuroendocrine carcinomas of the uterine cervix: a multi-center retrospective study","volume":"148","author":"Ishikawa","year":"2018","journal-title":"Gynecol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1692412\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T05:17:59Z","timestamp":1762751879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1692412\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":31,"alternative-id":["10.3389\/fonc.2025.1692412"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1692412","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"article-number":"1692412"}}